Blogs about: Monoclonal
Featured Blog
ImClone initiate Phase II trial of IMC-1121B in ovarian cancer
ImClone have initiated a phase II clinical trial of VEGFR-2 MAb IMC-1121B in patients with advanced ovarian cancer.… more →
Kinase News
The Future of Monoclonal Antibodies - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
aarkstore wrote 3 weeks ago: Summary The leading business intelligence provider, has released its latest research “The Future of … more →
Protein Therapeutics Markets (Antithrobins, Cytokines, Growth Hormones, Hematopoietics, Insulin, Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments)
aarkstore wrote 8 months ago: The substances utilized for what is commonly referred to as ‘protein therapeutics’ have … more →
5th Annual Monoclonal Antibodies
gkrcresearch wrote 11 months ago: 5th Annual Monoclonal Antibodies To be held at 24th – 25th March 2009, London, UK Monoclonal a … more →
ImClone initiate Phase II trial of IMC-1121B in ovarian cancer
crimsoncanary wrote 1 year ago: ImClone have initiated a phase II clinical trial of VEGFR-2 MAb IMC-1121B in patients with advanced … more →
Roche to initiate Phase II trial of IGF-1R MAb R1507 in NSCLC
crimsoncanary wrote 1 year ago: Roche and Genmab are preparing to initatea phase II trial of IGF-1R MAb R1507 in NSCLC in combinatio … more →
ImClone initiate randomized Phase II trial of IMC-A12 in breast cancer
crimsoncanary wrote 1 year ago: ImClone Systems have initiated a phase II clinical trial of its anti-IGF-1R MAb IMC-A12 in women wit … more →
Pfizers IGF-1R MAb CP-751,871 effective in NSCLC
crimsoncanary wrote 1 year ago: Phase II data presented at the European of Medical Oncology (ESMO) show that Pfizer’s IGF-1R i … more →
E Mercks Matuzumab effective in pancreatic cell lines/models
crimsoncanary wrote 1 year ago: E Mercks Matuzumab (EMD72000) reduced ErbB-1 phosphorylation and downstream MAPK and AKT signaling i … more →
Merrimack initiate phase I trial of ErbB3 MAb MM-121
crimsoncanary wrote 1 year ago: Merrimack Pharmaceuticals have initiated a phase I clinical study of ErbB3 MAb MM-121 for the treatm … more →
ImClone initiate Phase II study of IGF-1R MAb for Advanced Soft Tissue Sarcoma
crimsoncanary wrote 1 year ago: ImClone Systems have announced the start of a Phase II clinical trial of IMC-A12, its IGF-1R monoclo … more →
Takeda submit Japanese NDA for panitumumab in progressed and/or relapse colorectal cancer
crimsoncanary wrote 1 year ago: Takeda have submitted a New Drug Application to the Ministry of Health Labour and Welfare in Japan f … more →
Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Panitumumab
crimsoncanary wrote 1 year ago: Data presented today at the 10th World Congress on Gastrointestinal Cancer shows that preemptive tre … more →
Pfizer present data on CP-751,871 in NSCLC
crimsoncanary wrote 1 year ago: Data presented at ASCO show Pfizer’s IGF-R1MAb CP-751,871 to demonstrate efficacy in non-small … more →
Singapore's BTI signs pact with Raven
BCC Research wrote 1 year ago: *Updated with a more detailed article* New Article Linked Below read more | digg story ¹BioSpectrum … more →
Singapore Bioprocessing Technology Institute join hands with Raven to develop medicine for the future
BCC Research wrote 1 year ago: Collaboration will boost monoclonal antibody R&D and develop novel stem cell antibodies for diag … more →
animation for immunity and microbiology ( 1 )
— 9 comments
pharma2010 wrote 1 year ago: monoclonal antibody production http://www.esnips.com/doc/76e2c23d-1f14-4b7c-af4d-fb257b520bdd/Chapte … more →
